Skip to main content
SpringerLink
Log in

Qualitative Assessments of Adherence

  • Chapter
  • First Online:
Drug Adherence in Hypertension and Cardiovascular Protection

Part of the book series: Updates in Hypertension and Cardiovascular Protection ((UHCP))

Abstract

The diagnosis of non-adherence to prescribed medications is a real challenge in clinical medicine. Besides objective methods such as measurements of drug concentrations in plasma or urine and electronic monitoring of adherence, several qualitative approaches are available, which are based on self-report medication adherence scales or specific questionnaires. In a recent systematic review, more than 43 adherence scales have been reported that have been used essentially in chronic diseases including essential hypertension. Although self-reports and questionnaires are considered to have a low reliability to detect a poor medication-taking process, they do provide additional information, which cannot be obtained with objective measures. Thus, adequately validated questionnaires can identify relevant barriers and beliefs to a good medication-taking behavior. Therefore, these approaches should be considered as complementary to the objective measures of adherence and should perhaps not be totally disregarded as they often are.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sabaté E. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.

    Google Scholar 

  2. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43:521–30.

    Article  PubMed  Google Scholar 

  3. Corrao G, Parodi A, Nicotra F, Zambon A, Merlino L, Cesana G, Mancia G. Better compliance to antihypertensive medications reduces cardiovascular risk. J Hypertens. 2011;29:610–8.

    Article  CAS  PubMed  Google Scholar 

  4. Hill MN, Miller NH, DeGeest S, American Society of Hypertension Writing Group. ASH position paper: Adherence and persistence with taking medication to control high blood pressure. J Clin Hypertens (Greenwich). 2010;12:757–64.

    Article  Google Scholar 

  5. Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother. 2004;38:303–12.

    Article  PubMed  Google Scholar 

  6. Krousel-Wood M, Thomas S, Muntner P, Morisky D. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol. 2004;19:357–62.

    Article  PubMed  Google Scholar 

  7. Nguyen TM, La Caze A, Cottrell N. What are validated self-report adherence scales really measuring?: a systematic review. Br J Clin Pharmacol. 2014;77:427–45.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Stirratt MJ, Dunbar-Jacob J, Crane HM, Simoni JM, Czajkowski S, Hilliard ME, Aikens JE, Hunter CM, Velligan DI, Huntley K, Ogedegbe G, Rand CS, Schron E, Nilsen WJ. Self-report measures of medication adherence behavior: recommendations on optimal use. Transl Behav Med. 2015;5:470–82.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Zeller A, Taegtmeyer A, Martina B, Battegay E, Tschudi P. Physicians’ ability to predict patients’ adherence to antihypertensive medication in primary care. Hypertens Res. 2008;31:1765–71.

    Article  PubMed  Google Scholar 

  10. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487–97.

    Article  CAS  PubMed  Google Scholar 

  11. Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 2011;86:304–14.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Straka RJ, Fish JT, Benson SR, Suh JT. Patient self-reporting of compliance does not correspond with electronic monitoring: an evaluation using isosorbide dinitrate as a model drug. Pharmacotherapy. 1997;17:126–32.

    PubMed  CAS  Google Scholar 

  13. Wright EC. Non-compliance—or how many aunts has Matilda? Lancet. 1993;342:909–13.

    Article  CAS  PubMed  Google Scholar 

  14. Davis TME, Strong J, Bloom SR. Compliance in diabetes mellitus: a self-assessment study. Pract Diabetes. 1988;5:170–2.

    Article  Google Scholar 

  15. Fodor GJ, Kotrec M, Bacskai K, Dorner T, Lietava J, Sonkodi S, Rieder A, Turton P. Is interview a reliable method to verify the compliance with antihypertensive therapy? An international central-European study. J Hypertens. 2005;23(6):1261.

    Article  CAS  PubMed  Google Scholar 

  16. Perez-Escamilla B, Franco-Trigo L, Moullin JC, Martinez-Martinez F, Garcia-Corpas JP. Identification of validated questionnaires to measure adherence to pharmacological antihypertensive treatments. Patient Prefer Adherence. 2015;9:569–78.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67–74.

    Article  CAS  PubMed  Google Scholar 

  18. Schroeder K, Fahey T, Hay AD, Montgomery A, Peters TJ. Adherence to antihypertensive medication assessed by self-report was associated with electronic monitoring compliance. J Clin Epidemiol. 2006;59:650–1.

    Article  PubMed  Google Scholar 

  19. Willey C, Redding C, Stafford J, Garfield F, Geletko S, Flanigan T, Melbourne K, Mitty J, Caro JJ. Stages of change for adherence with medication regimens for chronic disease: development and validation of a measure. Clin Ther. 2000;22:858–71.

    Article  CAS  PubMed  Google Scholar 

  20. Svarstad BL, Chewning BA, Sleath BL, Claesson C. The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999;37:113–24.

    Article  CAS  PubMed  Google Scholar 

  21. Kim MT, Hill MN, Bone LR, Levine DM. Development and testing of the hill-bone compliance to high blood pressure therapy scale. Prog Cardiovasc Nurs. 2000;15:90–6.

    Article  CAS  PubMed  Google Scholar 

  22. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10:348–54.

    Article  Google Scholar 

  23. Culig J, Leppee M. From Morisky to Hill-bone; self-reports scales for measuring adherence to medication. Coll Antropol. 2014;38:55–62.

    PubMed  Google Scholar 

  24. Hamilton GA. Measuring adherence in a hypertension clinical trial. Eur J Cardiovasc Nurs. 2003;2:219–28.

    Article  PubMed  Google Scholar 

  25. Shi L, Liu J, Fonseca V, Walker P, Kalsekar A, Pawaskar M. Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis. Health Qual Life Outcomes. 2010;8:99.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Lambert EV, Steyn K, Stender S, Everage N, Fourie JM, Hill M. Cross-cultural validation of the hill-bone compliance to high blood pressure therapy scale in a South African, primary healthcare setting. Ethn Dis. 2006;16:286–91.

    PubMed  Google Scholar 

  27. Koschack J, Marx G, Schnakenberg J, Kochen MM, Himmel W. Comparison of two self-rating instruments for medication adherence assessment in hypertension revealed insufficient psychometric properties. J Clin Epidemiol. 2010;63:299–306.

    Article  PubMed  Google Scholar 

  28. Karademir M, Koseoglu IH, Vatansever K, Van Den Akker M. Validity and reliability of the Turkish version of the Hill-Bone compliance to high blood pressure therapy scale for use in primary health care settings. Eur J Gen Pract. 2009;15:207–11.

    Article  PubMed  Google Scholar 

  29. Zeller A, Schroeder K, Peters TJ. An adherence self-report questionnaire facilitated the differentiation between nonadherence and nonresponse to antihypertensive treatment. J Clin Epidemiol. 2008;61:282–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Service of Nephrology and Hypertension, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

    Michel Burnier & Grégoire Wuerzner

Authors
  1. Michel Burnier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Grégoire Wuerzner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michel Burnier .

Editor information

Editors and Affiliations

  1. Service of Nephrology and Hypertension, CHUV, University of Lausanne, Lausanne, Vaud, Switzerland

    Michel Burnier

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Burnier, M., Wuerzner, G. (2018). Qualitative Assessments of Adherence. In: Burnier, M. (eds) Drug Adherence in Hypertension and Cardiovascular Protection. Updates in Hypertension and Cardiovascular Protection. Springer, Cham. https://doi.org/10.1007/978-3-319-76593-8_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-76593-8_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-76592-1

  • Online ISBN: 978-3-319-76593-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation